美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

基因編輯

386.19

+8.472.24%

漲家數：2

跌家數：4

平家數：- -

市盈率：- -

高：396.79

開：370.33

低：358.51

收：377.72

資料載入中...

Beam Therapeutics Inc.盤中異動早盤急速下挫5.18%報23.80美元

Sangamo Therapeutics, Inc.盤中異動股價大跌5.46%報0.870美元

數據：在PEPE、BEAM等代幣上損失千萬美元的巨鯨轉向購買BTC和MKR

在PEPE、BEAM等代幣上損失千萬美元的巨鯨轉向購買BTC和MKR

Beam Therapeutics Inc.盤中異動下午盤股價大跌5.13%報24.99美元

Intellia Therapeutics, Inc.盤中異動大幅下挫5.00%報9.59美元

Editas Medicine, Inc.盤中異動早盤大幅下跌5.15%報1.82美元

藍鳥生物盤中異動早盤股價大跌5.82%

某巨鯨以1.17美元均價增持534萬枚ONDO，曾投資PEPE及BEAM虧損超1400萬美元

某巨鯨拋售去年10月囤積的5317億枚PEPE，虧損702萬美元

某巨鯨近一小時內賣出5317億枚PEPE，虧損702萬美元

藍鳥生物盤中異動早盤股價大漲5.26%報4.00美元

Intellia Therapeutics, Inc.盤中異動股價大跌5.66%報10.25美元

BUZZ-Intellia Therapeutics 第四季度合作收入好於預期，業績大幅增長

Sangamo Therapeutics, Inc.盤中異動股價大漲5.21%報1.030美元

Crispr Therapeutics Ag盤中異動股價大漲5.03%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4556/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因編輯","latestPrice":386.18573,"timestamp":1741121999999,"preClose":377.71658,"halted":0,"volume":17768398,"delay":0,"changeRate":0.022422,"change":8.469147,"pbRate":1.964243,"amount":211526710.593392,"amplitude":0.101341,"prevYearClose":376.62552,"fiveDayClose":416.6693,"twentyDayClose":372.1866,"turnoverRate":0.032555,"marketCap":7174775988,"floatMarketCap":6727985600,"peRate":-3.872729},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":396.7891,"amplitude":0.101341,"preClose":377.71658,"low":358.5108,"pbRate":"1.964243","latestPrice":386.18573,"volume":17768398,"delay":0,"open":370.32962,"prevYearClose":376.62552,"prevWeekClose":396.1103,"prevMonthClose":396.1103,"prevQuarterClose":376.6255,"fiveDayClose":416.6693,"twentyDayClose":372.1866,"sixtyDayClose":408.1032,"secType":"PLATE","market":"US","turnoverRate":0.032555,"peRate":-3.872729,"marketCap":7174775988,"floatMarketCap":6727985600,"timestamp":1741121999999,"nameCN":"基因編輯"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":2,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:16,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516670089","title":"Beam Therapeutics Inc.盤中異動 早盤急速下挫5.18%報23.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516670089?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:52","pubTimestamp":1741099972,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Beam Therapeutics Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报23.80美元/股，成交量20.2093万股，换手率0.24%，振幅2.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4556","BK4505","LENZ","BK4139","BK4535","BK4588","BK4585"],"gpt_icon":0},{"id":"2516459677","title":"Sangamo Therapeutics, Inc.盤中異動 股價大跌5.46%報0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516459677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516459677?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:31","pubTimestamp":1741098687,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Sangamo Therapeutics, Inc.股票出现异动，股价快速跳水5.46%。截至发稿，该股报0.870美元/股，成交量10.655万股，换手率0.05%，振幅1.00%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223127a25f0422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223127a25f0422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMO","BK4556","LENZ"],"gpt_icon":0},{"id":"2516619511","title":"數據：在PEPE、BEAM等代幣上損失千萬美元的巨鯨轉向購買BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516619511","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516619511?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 12:42","pubTimestamp":1741063374,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896779398776512797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4556","BEAM","BK4585","MKR.USD.HKCC","BK4601","BTC","BK4535","BK4588","BTC.USD.HKCC","ETH","BK4505","MKR.USD.CC","BK4139","XBTmain","ETH.USD.HKCC","BTCmain"],"gpt_icon":0},{"id":"2516160726","title":"在PEPE、BEAM等代幣上損失千萬美元的巨鯨轉向購買BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516160726","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516160726?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 12:31","pubTimestamp":1741062673,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 据 Onchain Lens 监测，在 PEPE 和 BEAM 中损失了 1414 万美元后，某鲸鱼在 ONDO 上再次损失了 85.3 万美元。\n此后其花费 533 万枚 DAI 以 84,150 美元的价格购买 63.42 枚 WBTC，使用价值 153 万美元的 wstETH 以 1,416 美元的价格购买 1,087.32 枚 MKR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/421646?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["ETH.USD.HKCC","BTCmain","BK4535","BK4585","BTC","MKR.USD.HKCC","BK4601","MKR.USD.CC","BK4505","BK4139","ETH","XBTmain","BK4556","BEAM","BTC.USD.HKCC","BK4588"],"gpt_icon":0},{"id":"2516663938","title":"Beam Therapeutics Inc.盤中異動 下午盤股價大跌5.13%報24.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516663938?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 04:28","pubTimestamp":1741033681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，Beam Therapeutics Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报24.99美元/股，成交量81.582万股，换手率0.97%，振幅6.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LENZ","BK4585","BK4535","BK4556","BK4505","BEAM"],"gpt_icon":0},{"id":"2516657315","title":"Intellia Therapeutics, Inc.盤中異動 大幅下挫5.00%報9.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516657315?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 02:46","pubTimestamp":1741027611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时46分，Intellia Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024651989a4900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024651989a4900&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","LU1861559042.SGD","LU1861558580.USD","BK4139","BK4556","NTLA","BK4535","BK4588"],"gpt_icon":0},{"id":"2516583936","title":"Editas Medicine, Inc.盤中異動 早盤大幅下跌5.15%報1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516583936?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:33","pubTimestamp":1741016000,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时33分，Editas Medicine, Inc.股票出现波动，股价大幅下跌5.15%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2111.16%、136.36%、127.52%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233320989a1ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303233320989a1ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2516632017","title":"藍鳥生物盤中異動 早盤股價大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516632017?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 22:45","pubTimestamp":1741013150,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时45分，蓝鸟生物股票出现异动，股价快速下跌5.82%。截至发稿，该股报3.84美元/股，成交量4.1416万股，换手率0.43%，振幅4.90%。机构评级方面，在所有7家参与评级的机构中，14%的券商给予买入建议，86%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224550989a1381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224550989a1381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BLUE","BK4578","BK4556"],"gpt_icon":0},{"id":"2516786035","title":"某巨鯨以1.17美元均價增持534萬枚ONDO，曾投資PEPE及BEAM虧損超1400萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516786035","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516786035?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 10:58","pubTimestamp":1740970730,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896388254917955585","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4139","BK4556","BK4505","BK4588","BK4585","MKR.USD.HKCC","BEAM","BK4535"],"gpt_icon":0},{"id":"2516519003","title":"某巨鯨拋售去年10月囤積的5317億枚PEPE，虧損702萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516519003","media":"世链财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516519003?lang=zh_tw&edition=fundamental","pubTime":"2025-03-02 18:09","pubTimestamp":1740910140,"startTime":"0","endTime":"0","summary":"3 月 2 日，据 OnchainLens 监测，某巨鲸近一小时抛售 5317 亿枚 PEPE 换得 410 万枚 DAI，亏损 702 万美元。该巨鲸曾于 2024 年 10 月份花费 1110 万美元购买这些 PEPE 代币。该巨鲸还卖出了 8800 万枚 BEAM 换得 70.9 万枚 DAI","market":"us","thumbnail":"https://m.shilian.com/assets/addons/cms/img/noimage/56.jpg","type":0,"news_type":0,"thumbnails":["https://m.shilian.com/assets/addons/cms/img/noimage/56.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.shilian.com//kuaixun/786881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"shilian_live","symbols":["MKR.USD.HKCC","BEAM","BK4556","BK4139","BK4505","BK4585","BK4535","BK4588"],"gpt_icon":0},{"id":"2516515163","title":"某巨鯨近一小時內賣出5317億枚PEPE，虧損702萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516515163","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516515163?lang=zh_tw&edition=fundamental","pubTime":"2025-03-02 18:05","pubTimestamp":1740909902,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 据 Onchain Lens 监测，某巨鲸近一小时内卖出 5317 亿枚 PEPE 换取 410 万枚 DAI，亏损 702 万美元，该巨鲸于 2024 年 10 月份花费 1110 万美元 PEPE。\n此外，该巨鲸还卖出了 8800 万枚 BEAM 换取 70.9 万枚 DAI，该地址还持有 1736 万枚 BEAM，约合 141 万美元，此前以 928 万美元买入 BEAM，亏损 715 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/421327?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BEAM","MKR.USD.HKCC","BK4505","BK4535","BK4585","BK4139","BK4588","BK4556"],"gpt_icon":0},{"id":"2514937300","title":"藍鳥生物盤中異動 早盤股價大漲5.26%報4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514937300?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 23:19","pubTimestamp":1740755946,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时19分，蓝鸟生物股票出现波动，股价快速上涨5.26%。截至发稿，该股报4.00美元/股，成交量2.9904万股，换手率0.31%，振幅6.84%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.22%。该信息摘要如下：毕竟蓝鸟生物曾是全球基因疗法领域的先驱，公司先后共推出三款“天价”产品，市值也一度逼近300亿美元。上市后，蓝鸟生物股价一路高歌猛进，市值一度逼近300亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231907963424dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231907963424dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BLUE","BK4578"],"gpt_icon":0},{"id":"2514932007","title":"Intellia Therapeutics, Inc.盤中異動 股價大跌5.66%報10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514932007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514932007?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 22:31","pubTimestamp":1740753092,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Intellia Therapeutics, Inc.股票出现波动，股价快速跳水5.66%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223132a25800fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223132a25800fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","LU1861558580.USD","BK4556","BK4139","NTLA","BK4535","BK4585","LENZ","BK4588"],"gpt_icon":0},{"id":"2514874543","title":"BUZZ-Intellia Therapeutics 第四季度合作收入好於預期，業績大幅增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874543","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514874543?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 00:42","pubTimestamp":1740674572,"startTime":"0","endTime":"0","summary":"2月27日 -  ** 总部位于马萨诸塞州的基因编辑公司Intellia Therapeutics NTLA.O股价上涨8.4%，报11.71美元 *  * 根据LSEG汇编的数据，公司第四季度合作收入为1290万美元，高于分析师预计的850万美元。** 公司的销售额主要受Regeneron REGN.O  协议的合作收入推动，该协议旨在开发治疗神经和肌肉疾病的基因编辑疗法。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3T3PI1V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2362541273.HKD","SIVBQ","LU2362540622.SGD","LU0289739699.SGD","BK4207","BK4585","LU0823416689.USD","LU2089984988.USD","LU2362541513.USD","LU0320765992.SGD","BK4211","LU1917777945.USD","NTLA","BK4589","BK4556","LU0889565916.HKD","BK4139","LU2023250504.SGD","LU1861558580.USD","LU2468319806.SGD","LU1974910355.USD","LU1861559042.SGD","BK4588","REGN","LU2237438978.USD","LU0114720955.EUR","LU0109394709.USD","LU0058720904.USD","LU2106854487.HKD","LU0053666078.USD","BK4535"],"gpt_icon":0},{"id":"2514384070","title":"Sangamo Therapeutics, Inc.盤中異動 股價大漲5.21%報1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514384070?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:57","pubTimestamp":1740671839,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时57分，Sangamo Therapeutics, Inc.股票出现异动，股价快速上涨5.21%。截至发稿，该股报1.030美元/股，成交量116.742万股，换手率0.56%，振幅6.95%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723572098952223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723572098952223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","SGMO","BK4139","LENZ"],"gpt_icon":0},{"id":"2514381222","title":"Crispr Therapeutics Ag盤中異動 股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381222?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:11","pubTimestamp":1740669085,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨5.03%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.79%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272311259632ba0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272311259632ba0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","BK4588","BK4139","LU1861559042.SGD","LENZ","LU1861558580.USD","BK4556","BK4585"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":1,"totalSize":47}]}}